Total Payments
$434.26
2024 Payments
$142.04
Companies
8
Transactions
12
Medicare Patients
1,335
Medicare Billing
$121,591
Payment Breakdown by Category
Food & Beverage$434.26 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $434.26 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $121.84 | 1 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $106.58 | 4 | $0 (2024) |
| AbbVie Inc. | $97.99 | 1 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $41.30 | 2 | $0 (2024) |
| Lundbeck LLC | $19.46 | 1 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17.20 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $15.71 | 1 | $0 (2024) |
| Indivior Inc. | $14.18 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $142.04 | 7 | Neurocrine Biosciences, Inc. ($64.67) |
| 2023 | $152.32 | 3 | Novo Nordisk Inc ($121.84) |
| 2022 | $41.91 | 1 | Neurocrine Biosciences, Inc. ($41.91) |
| 2021 | $97.99 | 1 | AbbVie Inc. ($97.99) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Neuropsychiatry | ||||||
| 08/28/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Neurology | ||||||
| 07/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Neuropsychiatry | ||||||
| 05/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.46 | General |
| Category: PSYCHIATRY | ||||||
| 05/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Neuropsychiatry | ||||||
| 10/26/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: BH | ||||||
| 08/01/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: PSYCHIATRY | ||||||
| 05/18/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $121.84 | General |
| 01/06/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $41.91 | General |
| Category: Neuropsychiatry | ||||||
| 06/02/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $97.99 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 286 | 341 | $89,477 | $24,629 |
| 2022 | 4 | 339 | 412 | $88,023 | $28,575 |
| 2021 | 7 | 318 | 433 | $94,352 | $27,007 |
| 2020 | 11 | 392 | 642 | $131,173 | $41,381 |
Total Patients
1,335
Total Services
1,828
Medicare Billing
$121,591
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 125 | 161 | $43,105 | $12,419 | 28.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 55 | 56 | $21,949 | $5,637 | 25.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 84 | 102 | $18,004 | $5,124 | 28.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 22 | $6,419 | $1,448 | 22.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 160 | 215 | $43,226 | $14,247 | 33.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 57 | $22,173 | $7,096 | 32.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 99 | 116 | $16,240 | $5,398 | 33.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 24 | 24 | $6,384 | $1,835 | 28.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 111 | 153 | $32,486 | $10,023 | 30.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 50 | 50 | $20,616 | $6,560 | 31.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 63 | 87 | $12,904 | $4,087 | 31.7% |
| 99335 | Established patient assisted living visit, typically 25 minutes | Office | 2021 | 38 | 83 | $15,550 | $3,577 | 23.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 17 | 17 | $4,737 | $1,271 | 26.8% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2021 | 20 | 20 | $5,329 | $960.10 | 18.0% |
| 99334 | Established patient assisted living visit, typically 15 minutes | Office | 2021 | 19 | 23 | $2,730 | $528.39 | 19.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 110 | 159 | $33,772 | $10,729 | 31.8% |
| 99335 | Established patient assisted living visit, typically 25 minutes | Office | 2020 | 53 | 173 | $32,412 | $10,644 | 32.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 42 | 42 | $17,359 | $5,363 | 30.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 63 | 81 | $12,014 | $3,824 | 31.8% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2020 | 21 | 40 | $10,658 | $3,531 | 33.1% |
| 99334 | Established patient assisted living visit, typically 15 minutes | Office | 2020 | 33 | 69 | $8,190 | $2,453 | 29.9% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 16 | 23 | $4,289 | $1,409 | 32.8% |
| 99326 | New patient assisted living visit, typically 45 minutes | Office | 2020 | 12 | 12 | $3,313 | $1,043 | 31.5% |
| 99356 | Prolonged inpatient or observation hospital service first hour | Facility | 2020 | 14 | 15 | $2,799 | $924.35 | 33.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 16 | 16 | $4,458 | $879.58 | 19.7% |
About Caroline Baker, NP
Caroline Baker, NP is a Family healthcare provider based in Upper Arlington, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2016. The National Provider Identifier (NPI) number assigned to this provider is 1558713487.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Caroline Baker, NP has received a total of $434.26 in payments from pharmaceutical and medical device companies, with $142.04 received in 2024. These payments were reported across 12 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($434.26).
As a Medicare-enrolled provider, Baker has provided services to 1,335 Medicare beneficiaries, totaling 1,828 services with total Medicare billing of $121,591. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Upper Arlington, OH
- Active Since 07/03/2016
- Last Updated 12/09/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1558713487
Products in Payments
- INGREZZA (Drug) $106.58
- UBRELVY (Drug) $97.99
- REXULTI (Drug) $35.76
- ABILIFY ASIMTUFII (Drug) $25.00
- CAPLYTA (Drug) $17.20
- UZEDY (Drug) $15.71
- PERSERIS (Drug) $14.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Upper Arlington
Brooke Laturell
Family — Payments: $873.90
Family $873.90
Peter Dipiazza, Dnp, Bc-Fnp, DNP, BC-FNP
Family — Payments: $644.43
Family $644.43
Laura Seiler, Np, NP
Family — Payments: $352.74
Family $352.74
Taylor Hale, Np, NP
Family — Payments: $260.96
Family $260.96
Cassandra Bernard
Family — Payments: $234.39
Family $234.39
Amy Canini, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $211.30
Family $211.30